Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The MicroRNA Market Expected To Grow In Terms Of Size?

The size of the microrna market has expanded at a brisk pace over the latest years. The market is projected to rise from $1.33 billion in 2024 to $1.57 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 18.6%. Factors such as the discovery of microRNAs, RNA interference (RNAi), genome sequencing projects, computational biology and bioinformatics, and the research on extracellular vehicles (EVs) have contributed to the growth seen in the previous period.

In the forthcoming years, the microrna market size is anticipated to experience quick expansion. It is projected to reach $2.95 billion by 2029, with a compound annual growth rate (CAGR) of 17.0%. The growth during this period can be associated with factors such as clinical translation, regulatory systems and networks, microRNA-based therapies, therapeutic potential, and biomarker discovery. The forecast period will also witness certain significant trends that include technological innovations, bioinformatics, and data interpretation, and aspects like cross-species conservation, interactions of the microbiome, and functional mechanisms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp

What Are The Primary Factors Supporting The MicroRNA Market Expansion?

The surge in cancer incidences is anticipated to boost the expansion of the microRNA market in the future. Cancer is a complicated disease known for unregulated cell growth and proliferation, which often results in the development of malignant tumors that hold the potential to invade adjacent tissues and metastasize to remote organs, thereby posing considerable health hazards. The escalating cancer incidences can be attributed to diverse factors such as an aging populace, lifestyle decisions like smoking and inappropriate diet, environmental contaminants, and better detection techniques leading to early diagnosis. Integration of microRNA with conventional cancer treatments is done to increase drug effectiveness and enhance outcomes. Apart from their role in treatment, microRNAs serve as diagnostic and prognostic biomarkers, assisting in cancer type identification, predicting disease advancement, and monitoring responses to treatment. For instance, in May 2024, about 20 million fresh cases and 9.7 million cancer-associated deaths were reported annually in 2022 by the National Cancer Institute, a US-based government organization, and forecasts suggest that by 2040, about 15.3 million deaths and 29.9 million fresh cases may occur each year. Thus, the rise in cancer cases is fueling the expansion of the microRNA market.

Which Segmentation Categories Are Highlighted In The MicroRNA Market Analysis?

The micrornamarket covered in this report is segmented –

1) By Products: Instruments; Consumables

2) By Assay Type: Immunoassay; Next Generation Sequencing; miRNA Arrays; Polymerase Chain Reaction (PCR) Based Arrays

3) By Application: Cancer; Infectious Diseases; Immunological Disorder; Cardiovascular Disease; Neurological Disease; Other Applications

4) By End User: Academic And Research Institutes; Biopharmaceutical Companies; Diagnostic Centers; Clinical Research Organizations

Subsegments:

1) By Instruments: Qpcr Systems (Quantitative Pcr); Microarray Platforms; Next-Generation Sequencing (Ngs) Systems; Real-Time Pcr Instruments; Microrna Analyzers

2) By Consumables: Microrna Kits ( Extraction Kits, Detection Kits); Pcr Reagents; Primers And Probes; Microarrays And Chips; Rna Sequencing Kits

Which Trends Are Likely To Redefine Growth Paths In The MicroRNA Market?

Leading organizations in the microRNA marketplace are concentrating on devising innovative solutions such as MiRNA probe personalization services to meet the particular requirements of researchers and clinicians, improve miRNA detection precision, and support a broad array of applications. Services for MiRNA probe customization pertain to the specialized services extended by biotechnology and molecular biology organizations for the development and manufacture of probes tailored to specific microRNAs (miRNAs) for different research and clinical uses. For example, in September 2023, Abnova Corporation, a biotech firm based in Taiwan, inaugurated enhanced services for personalizing miRNA probes, in addition to launching a novel selection of cataloged miRNA probes, with the aim of catering to the varied demands of the academic, industrial, and research communities involved in miRNA research. These probes are critical in identifying and accurately pinpointing miRNAs, tiny RNA molecules without coding functions yet essential for many biological activities. Abnova’s personalization services guarantee high specificity and minimum cross-reactivity, which makes them ideal for examination of samples possessing limited miRNA content.

Which Organizations Are At The Forefront Of The MicroRNA Market?

Major companies operating in the MicroRNA market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Kaneka Corporation, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Biodynamics Laboratory Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Biogenex Laboratories, Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc., Synlogic Inc., Sistemic Scotland Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/microrna-global-market-report

Which Geographic Regions Are Creating Strong Demand In The MicroRNA Market?

North America was the largest region in the microRNA market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the MicroRNA market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp

Browse Through More Reports Similar to the Global MicroRNA Market 2025, By The Business Research Company

Mycoplasma Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Antiphospholipid Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

Cartilage Repair Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cartilage-repair-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model